acute caffeine ingestion significantly increased fmd (patients with cad 5.6 ± 5.0% vs 14.6 ± 5.0%, controls 8.4 ± 2.9% vs 18.6 ± 6.8%, p <0.001 for all comparisons) but not ntg (patients with cad 13.0 ± 5.2% vs 13.8 ± 6.1%, controls 12.9 ± 3.9% vs 13.9 ± 5.8%, p = ns for all comparisons) and significantly decreased high-sensitivity c-reactive protein (patients with cad 2.6 ± 1.4 vs 1.4 ± 1.2 mg/l, controls 3.4 ± 3.0 vs 1.2 ± 1.0 mg/l, p <0.001 for all comparisons) in the 2 groups compared to placebo.